Zolmitriptan 5 mg/1 (Zolmitriptan TABLET, FILM COATED) 5 mg/1

Zolmitriptan 5 mg is a medication used for the acute treatment of migraine headaches. This oral tablet is designed to provide relief from migraine symptoms, including pain and associated discomfort.

Strength

5 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (16571-804-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Rising Pharma Holdings, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zolmitriptan 5 mg is commonly used to treat migraine headaches. It works by narrowing blood vessels around the brain and reducing substances in the body that can trigger migraine pain, nausea, sensitivity to light and sound, and other migraine symptoms. People often wonder, 'What is Zolmitriptan used for?' and the primary use is for the acute treatment of migraines.

Side Effects

Common effects of Zolmitriptan 5 mg may include dizziness, drowsiness, nausea, and dry mouth. Some users might experience tingling or warmth sensations. These effects can vary from person to person and are generally mild to moderate in severity.

Precautions & Warnings

Zolmitriptan 5 mg should be handled with care. It is important to follow the instructions provided by a healthcare professional. Avoid driving or operating heavy machinery if you experience drowsiness or dizziness. Store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Zolmitriptan 5 mg may interact with other medications, including selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). It is also advisable to avoid alcohol while taking this medication, as it can enhance certain side effects.

Frequently Asked Questions

Zolmitriptan is primarily used for the acute treatment of migraine headaches.

Zolmitriptan 5 mg is typically taken orally with or without food, as directed by a healthcare professional.

Common side effects may include dizziness, drowsiness, nausea, and dry mouth.

It is advisable to avoid alcohol while taking Zolmitriptan, as it can enhance certain side effects.

Store Zolmitriptan in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.